Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: a systematic review and meta-analysis

Abstract Background No consensus treatment has been reached for hepatocellular carcinoma (HCC) with portal vein tumor thrombus (PVTT). Hepatic resection (HR) and transarterial chemoembolization (TACE) have been recommended as effective options, but which is better remains unclear. This meta-analysis...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän:	Xiu-Ping Zhang, Kang Wang, Nan Li, Cheng-Qian Zhong, Xu-Biao Wei, Yu-Qiang Cheng, Yu-Zhen Gao, Han Wang, Shu-Qun Cheng
Materialtyp:	Artikel
Språk:	English
Publicerad:	BMC 2017-12-01
Serie:	BMC Cancer
Ämnen:	Hepatic resection Transarterial chemoembolization Hepatocellular carcinoma Portal vein tumor thrombus
Länkar:	http://link.springer.com/article/10.1186/s12885-017-3895-z

Liknande verk

Transarterial chemoembolization for hepatocellular carcinoma combined with portal vein tumor thrombosis
av: Lv WF, et al.
Publicerad: (2018-10-01)

Prognosis of patients with hepatocellular carcinoma and portal vein tumor thrombus treated with combination of transarterial chemoembolization and palliative thermal ablation
av: Qunfang Zhou, et al.
Publicerad: (2022-12-01)

Safety, efficacy, and survival of drug-eluting beads-transarterial chemoembolization vs. conventional-transarterial chemoembolization in advanced HCC patients with main portal vein tumor thrombus
av: Junwei Chen, et al.
Publicerad: (2023-07-01)

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis
av: Jung Min Lee, et al.
Publicerad: (2016-03-01)

Immune-Targeted Therapy with or without Transarterial Chemoembolization (TACE) for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis (PVTT): A Multicenter Retrospective Study
av: Ran You, et al.
Publicerad: (2024-09-01)

Comparison of surgical resection versus transarterial chemoembolization with additional radiation therapy in patients with hepatocellular carcinoma with portal vein invasion
av: Danbi Lee, et al.
Publicerad: (2018-06-01)

Safety and efficacy of low-dose transarterial chemoembolization in the hepatocellular carcinoma patients with portal vein tumor thrombosis
av: Won-Gyom Choe, et al.
Publicerad: (2018-01-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Tertiary Care Center Experience
av: Yashwant Patidar, et al.
Publicerad: (2021-04-01)

A multicenter prospective study of TACE combined with lenvatinib and camrelizumab for hepatocellular carcinoma with portal vein tumor thrombus
av: Xiaomi Li, et al.
Publicerad: (2023-08-01)

Development of a Prognostic Scoring System for Hepatocellular Carcinoma Patients With Main Portal Vein Tumor Thrombus Undergoing Conventional Transarterial Chemoembolization: An Analysis of 173 Patients
av: Jing-huan Li, et al.
Publicerad: (2021-08-01)

The Progress in the Treatment of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
av: Fangzhou Luo, et al.
Publicerad: (2021-09-01)

Comparison of intra-arterial chemoembolization with and without radiotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis: a meta-analysis
av: Zhao Q, et al.
Publicerad: (2016-12-01)

Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy
av: Lei Zhang, et al.
Publicerad: (2020-12-01)

The safety and efficacy of transarterial chemoembolization combined with sorafenib and sorafenib mono-therapy in patients with BCLC stage B/C hepatocellular carcinoma
av: Fei-Xiang Wu, et al.
Publicerad: (2017-09-01)

Efficacy and safety of endovascular brachytherapy combined with transarterial chemoembolization for the treatment of hepatocellular carcinoma patients with type III or IV portal vein tumor thrombosis
av: Ling Li, et al.
Publicerad: (2022-02-01)

Combined iodine-125 seed strand, portal vein stent, transarterial chemoembolization, lenvatinib and anti-PD-1 antibodies therapy for hepatocellular carcinoma and Vp4 portal vein tumor thrombus: A propensity-score analysis
av: Zi-Han Zhang, et al.
Publicerad: (2023-01-01)

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world
av: Jin-Kai Feng, et al.
Publicerad: (2022-11-01)

Sorafenib Versus Apatinib Both Combined Transarterial Chemoembolization for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis: A Comparative Retrospective Study
av: Yanyan Cao, et al.
Publicerad: (2021-08-01)

Development of a Prognostic Nomogram in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Following Trans-Arterial Chemoembolization with Drug-Eluting Beads
av: Cheng S, et al.
Publicerad: (2021-12-01)

Percutaneous Radiofrequency Ablation Combined With Transarterial Chemoembolization Plus Sorafenib for Large Hepatocellular Carcinoma Invading the Portal Venous System: A Prospective Randomized Study
av: Xiaoyan Ding, et al.
Publicerad: (2020-10-01)

TACE Combined with Portal Vein Tumor Thrombus 125I Seed Implantation in the Treatment of HCC with Hepatic Arterioportal Shunts
av: Xia WL, et al.
Publicerad: (2024-09-01)

Efficacy comparison of optimal treatments for hepatocellular carcinoma patients with portal vein tumor thrombus
av: Yu Zhang, et al.
Publicerad: (2022-01-01)

Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis
av: Moon Haeng Hur, et al.
Publicerad: (2023-07-01)

Efficacy of radiation plus transarterial chemoembolization and lenvatinib in hepatocellular carcinoma with portal vein tumor thrombus
av: Aoran Dong, et al.
Publicerad: (2023-12-01)

Complete remission of advanced hepatocellular carcinoma following transient chemoembolization and portal vein ligation
av: Yuki Koga, et al.
Publicerad: (2018-08-01)

Transarterial Chemoembolization Plus Lenvatinib and PD-1 Inhibitors for Hepatocellular Carcinoma with Main Trunk Portal Vein Tumor Thrombus: A Multicenter Retrospective Study
av: Li SQ, et al.
Publicerad: (2023-10-01)

Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
av: Jun Young Kim, et al.
Publicerad: (2016-06-01)

Transarterial Chemoembolization in Unresectable Hepatocellular Carcinoma with Portal Vein Thrombosis: A Perspective on Survival
av: Yadav Ajit, et al.
Publicerad: (2014-11-01)

Prospective study of TACE combined with sorafenib vs TACE combined with 125I seed implantation in the treatment of hepatocellular carcinoma with portal vein tumor thrombus and arterioportal fistulas
av: Xiao-Hui Zhao, et al.
Publicerad: (2022-10-01)

Combination of transcatheter arterial chemoembolization and portal vein embolization for patients with hepatocellular carcinoma: a review
av: Zhiying Shao, et al.
Publicerad: (2021-10-01)

Comparison of percutaneous microwave/radiofrequency ablation liver partition and portal vein embolization versus transarterial chemoembolization and portal vein embolization for planned hepatectomy with insufficient future liver remnant
av: Tai-Wei Ye, et al.
Publicerad: (2024-08-01)

Use of doxorubicin-eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma with portal vein invasion: a prospective study
av: Su Jong Yu, et al.
Publicerad: (2023-03-01)

Efficacy of Transarterial Chemoembolization Combined with Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombus: A Systematic Review and Meta-Analysis
av: Jia Deng, et al.
Publicerad: (2023-01-01)

Surgery for colloid carcinoma of the pancreas with portal vein tumor thrombus: a case report
av: Daisuke Udagawa, et al.
Publicerad: (2020-10-01)

Postoperative Adjuvant Transarterial Chemoembolization Improves Short-Term Prognosis of Hepatocellular Carcinoma with Bile Duct Tumor Thrombus: A Propensity-Score Matching Study
av: Huang Q, et al.
Publicerad: (2020-09-01)

DEM-TACE as the initial treatment could improve the clinical efficacy of the hepatocellular carcinoma with portal vein tumor thrombus: a retrospective controlled study
av: Junwei Chen, et al.
Publicerad: (2022-11-01)

Efficacy and Safety of Transarterial Chemoembolization for the Treatment of Unresectable Hepatocellular Carcinoma Associated with Bile Duct Tumor Thrombus: A Real-World Retrospective Cohort Study
av: Feng JK, et al.
Publicerad: (2021-04-01)

Effectiveness and safety of vascular intervention plus lenvatinib versus vascular intervention alone for hepatocellular carcinoma patients with portal vein tumor thrombus: a retrospective comparative study
av: Saikang Tang, et al.
Publicerad: (2024-07-01)

Outcomes of liver resection and transarterial chemoembolization in patients with multinodular BCLC-A hepatocellular carcinoma
av: Jiwon Yang, et al.
Publicerad: (2024-09-01)

Transarterial chemoembolization with insertion of radioactive seeds for hepatocellular carcinoma
av: You-Bin Wang, et al.
Publicerad: (2023-09-01)